Skip to content

June 2, 2023

Private Capital Journal
Private Capital Journal
Primary Navigation Menu
Menu
  • Deals
    • Venture Capital Deals
    • Private Equity Deals
    • Angel Deals
    • Private Deals
    • Public Deals
    • M&A/Exit Deals
    • IPO, RTO Deals
    • Government Funding
  • Funds/Firms
    • VC Funds
    • PE Funds
    • Pension Funds
    • Government Funds
    • Family Offices
    • Retail FundsRetail Funds, MICs, Public Traded Funds, Private Debt/Royalty Fund
    • Publicly Traded Funds
    • Financial Services
    • Infra Funds
    • Real Estate Funds
    • Mutual Funds
    • Accelerator Funds
    • Angel Funds
    • Merchant Banks
    • Law Firms
    • Accounting Firms
  • People
    • VC Firms
    • PE Firms
    • Pension Funds
    • Retail Funds/VCCs
    • Law Firms
    • Angel Groups
    • Investment Firms
    • Financial Advisors
    • Service Providers
    • EMDs
    • Portfolio
    • PCMA
  • Region
    • British Columbia
    • Alberta
    • Saskatchewan
    • Manitoba
    • Ontario
    • Quebec
    • New Brunswick
    • Nova Scotia
    • Prince Edward Island
    • Newfoundland and Labrador
    • Northwest Territories
    • Yukon
    • Nunavut
    • United States
    • Europe
    • Africa
    • Americas
    • Asia Pacific
    • Middle East
  • Sectors
    • IT and Telecom
    • Biotech and Life Sciences
    • HealthCare
    • CleanTech
    • Oil and Gas
    • Mining
    • Aerospace and Defence
    • Agri-Food
    • Business Products and Services
    • Consumer Products and Services
    • Education
    • Financial
    • Forestry
    • Industrial and Manufacturing
    • Media and Entertainment
    • Power and Utilities
    • Real Estate
    • Transportation and Logistics
  • Analysis
    • Analysis
    • Editorial
    • Deal of the Week
    • CPE Media Leaderboard
  • About Us
  • Advertise
  • Contact

Biotech and Life Sciences (Page 34)

Liberty Biopharma announces $10M prospectus offering

2017-03-29
On: March 29, 2017
In: British Columbia, Biotech and Life Sciences, Public Deals

Liberty Biopharma has engaged Kernaghan & Partners for a “best efforts” offering of up to $10MContinue Reading

DW Healthcare Partners Fund IV closes at US $295M

2017-03-29
On: March 29, 2017
In: PE Funds, Biotech and Life Sciences, HealthCare, Ontario, United States

DW Healthcare Partners Fund IV final closed at US $295M. Credit Suisse Securities (USA) acted as placement agent.Continue Reading

RockGarden Medicinals announces $1.53M financing

2017-03-29
On: March 29, 2017
In: Biotech and Life Sciences, Private Deals, Ontario

RockGarden Medicinals, intends to issue shares representing 25% of total shareholding for gross proceeds of $1.53M.
Continue Reading

LightIntegra appoints Bill Dubiel as President & CEO

2017-03-27
On: March 27, 2017
In: British Columbia, Biotech and Life Sciences, Portfolio

LightIntegra Technology appointed William “Bill” Dubiel as new President & CEO and a director. Continue Reading

Resolve Digital Health closes 1st round of financing – updated

2017-03-25
On: March 25, 2017
In: Biotech and Life Sciences, HealthCare, Private Deals, Ontario

Resolve Digital Health, a developer of smart inhaler tracking medical cannabis, has closed a private financing.
Continue Reading

Ventripoint Diagnostics closes $3.36M private placement

2017-03-24
On: March 24, 2017
In: Biotech and Life Sciences, Public Deals, Ontario

Ventripoint Diagnostics closed $3.36M private placement with existing shareholders and new subscribersContinue Reading

Prometic secures $25M new financing from Thomvest

2017-03-24
On: March 24, 2017
In: Venture Capital Deals, Biotech and Life Sciences, Ontario, Quebec

Peter J. Thomson’s Structured Alpha invests additional $25M in Prometic Life Sciences, bringing total loan investment to $85M. Continue Reading

Nexxus Capital to take Immunotec private for $34.3M

2017-03-22
On: March 22, 2017
In: Private Equity Deals, Biotech and Life Sciences, Quebec, Americas

Mauricio Domenzain in partnership with Nexxus Capital to take Immunotec for $34.3MContinue Reading

Canopy Growth closes $24.25M private financing

2017-03-22
On: March 22, 2017
In: Biotech and Life Sciences, Public Deals, Ontario

Canopy Growth closed $24.25M financing with one unnamed investor. Goldman Holdings agrees to lend free-trading shares to the investor.Continue Reading

Winston Resources closes $2.9M financing

2017-03-22
On: March 22, 2017
In: British Columbia, Biotech and Life Sciences, Public Deals

Winston Resources closed oversubscribed non-brokered private placement for $2.9MContinue Reading

FACIT invests in Propellon Therapeutics

2017-03-22
On: March 22, 2017
In: Venture Capital Deals, Biotech and Life Sciences, Ontario

Fight Against Cancer Innovation Trust announced a seed investment in Propellon Therapeutics.Continue Reading

Prevtec Microbia secures $2.5M funding led by Telesystem

2017-03-21
On: March 21, 2017
In: Venture Capital Deals, Biotech and Life Sciences, Quebec

Prevtec Microbia raised $2.5M from Telesystem Ltd., Desjardins-Innovatech, S.E.C., Grupo Corporativo Fuertes, S.L., Echo Capital FIER Outaouais, s.e.c.Continue Reading

FACIT launches evergreen Prospects Oncology Fund

2017-03-21
On: March 21, 2017
In: VC Funds, Biotech and Life Sciences, Ontario

Fight Against Cancer Innovation Trust launches evergreen Prospects Oncology Fund for early-stage Ontario cancer discoveriesContinue Reading

Aurinia Pharmaceuticals completes US $173M offering

2017-03-20
On: March 20, 2017
In: British Columbia, Biotech and Life Sciences, Public Deals

Aurinia Pharmaceuticals completed previously announced public offering for gross proceeds of US $173MContinue Reading

CVR Medical announces $5M financing

2017-03-20
On: March 20, 2017
In: British Columbia, Biotech and Life Sciences, Public Deals

CVR Medical to close an institutionally led non-brokered private placement for up to $5 million.Continue Reading

BELLUS Health sells Thallion to Taro for $2.7M

2017-03-17
On: March 17, 2017
In: Biotech and Life Sciences, M&A/Exit Deals, Quebec, Middle East

BELLUS Health to sell Thallion Pharmaceuticals and the drug candidate Shigamab to Taro for up to $2.7 million.Continue Reading

Titan Medical closes $7.5M offering

2017-03-16
On: March 16, 2017
In: Biotech and Life Sciences, Public Deals, Ontario

Titan Medical closed $7.5M offering led by Bloom Burton Securities with Roth Capital Partners acting as special selling group member.Continue Reading

Posts navigation

Previous 1 … 33 34 35 36 Next

Subscribe to Our Daily Summary

Confirmation Required - check your junk folder should you NOT receive our confirmation email immediately. Real name, please. (We never spam, but if you feel that we have no business in knowing your real name, please don’t subscribe. Our privacy policy)

Please confirm your subscription. Unconfirmed subscriptions will be removed within 24 hours.

Private Capital Journal – a publication of CPE News, Canada’s leading all private capital and public financing news

Privacy Policy
Terms of Use

© 2023 CPE News, a division of CPE Media & Data Company. All Rights Reserved. 500-245 Fairview Mall Drive, Toronto, Ontario M2J 4T1 | 647-872-6300